GuideCardiology

GARFIELD-AF risk tool (mortality, stroke and bleeding in atrial fibrillation)

GARFIELD-AF registry tool simultaneously estimating risk of death, stroke/systemic embolism and major bleeding up to 2 years in atrial fibrillation.

Updated 3 November 2026

When to use it

Patients with newly diagnosed atrial fibrillation, to compare expected outcomes with and without oral anticoagulation and support shared decision-making.

What it is

Model derived from the international prospective GARFIELD-AF registry (over 52,000 patients with newly diagnosed atrial fibrillation) and externally validated in ORBIT-AF and Danish registries. It integrates into one assessment the three outcomes that weigh on the anticoagulation decision.

Keep reading in the app

  • Variables
  • Performance
  • Practical use

Practical tip

It discriminates better than CHA2DS2-VASc and HAS-BLED, including in patients at low risk by those scores.

2 more practical tips in the app.

Reference

Official source: Official GARFIELD-AF calculator

A support tool for healthcare professionals: it guides and does not replace clinical judgement.

Back to top